Financial Assessment of the Global Pharmaceutical and Biotechnology Industry
Financial Assessment of the Global Pharmaceutical and Biotechnology Industry
Financial Management is the Key Strategy for Sustainability
22-Feb-2013
Global
$4,950.00
Special Price $3,712.50 save 25 %
Description
This financial assessment study analyzes the financial ratios of public companies across the globe in the pharmaceutical and biotechnology industry. The research objectives are to rank companies based on their financial and risk management while also identifying key trends that can impact the performance of industry participants over the next year. Those analyzed include 718 publicly-listed pharmaceutical and 482 publicly-listed biotechnology companies across the globe. To assess the financial performance, ratios are divided into four categories: profitability, liquidity, activity (turnover), and solvency. Top performers in each industry are also highlighted.
Table of Contents
Analysis of Financial Ratios of Public Companies in the Global Pharmaceutical and Biotechnology Industry
- Financial Assessment of Participants of Pharmaceutical and Biotechnology Industry
Popular Topics
No Index | Yes |
---|---|
Podcast | No |
Author | Saneesh Edacherian |
WIP Number | NBB7-01-00-00-00 |
Is Prebook | No |